KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Invested Capital (2019 - 2025)

Vir Biotechnology's Return on Invested Capital history spans 6 years, with the latest figure at 0.61% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 13.0% year-over-year to 0.61%; the TTM value through Dec 2025 reached 0.61%, down 13.0%, while the annual FY2025 figure was 0.5%, 7.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.61% at Vir Biotechnology, up from 0.63% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.69% in Q1 2022 and bottomed at 0.63% in Q3 2025.
  • The 5-year median for Return on Invested Capital is 0.38% (2024), against an average of 0.2%.
  • The largest annual shift saw Return on Invested Capital skyrocketed 124bps in 2022 before it plummeted -96bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.34% in 2021, then dropped by -21bps to 0.27% in 2022, then plummeted by -252bps to 0.41% in 2023, then decreased by -19bps to 0.49% in 2024, then fell by -26bps to 0.61% in 2025.
  • Per Business Quant, the three most recent readings for VIR's Return on Invested Capital are 0.61% (Q4 2025), 0.63% (Q3 2025), and 0.6% (Q2 2025).